Name:
Achromobacter marplatensis Gomila et al. 2011 emend. Vandamme et al. 2013 emend. Vandamme et al. 2016
Synonym(s):
Achromobacter spiritinus Vandamme et al. 2013
DSM No.:
29603 dsm-29603 dsm29603 dsm 29603 Achromobacter marplatensis
Other collection no.
or WDCM no.:
LMG 26692,CCUG 61968
Isolated from:
non-cystic fibrosis patient, sputum
Country:
United States of America
Date of sampling:
before January 2008
Nagoya Protocol Restrictions:
There are NO known Nagoya Protocol restrictions for this strain.
History:
<- LMG <- P. Vandamme, Univ. Ghent, Belgium <- J. J. LiPuma, Univ. Michigan, USA; LMG 26692
Genbank accession numbers:
Summary and
additional information:
<- LMG <- P. Vandamme, Univ. Ghent, Belgium <- J. J. LiPuma, Univ. Michigan, USA; LMG 26692. Non-cystic fibrosis patient, sputum; USA. Type strain of Achromobacter spiritinus. Taxonomy/description (17780, 17859, 25607). Sequence accession no. 16S rRNA gene: HE613447. (Medium 1, 30°C).
Risk group:
2 (classification according to German
TRBA)
Restrictions:
Act dealing with the prevention & control of infectious diseases in man (Infektionsschutzgesetz),
Category A1
Supplied as:
| Delivery form | | Prices |
|
| Freeze Dried | | 100,- € |
| Active culture on request | | 240,- € |
| DNA | | 150,- € | |
| Price Category for this culture: 1 |
Freight and handling charges will be added.
See price list.Note: Freight charges for Risk Group 2 microorganisms will apply.
